A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis
Xiaolong Huang(Fujian Medical University), Xiaoni Zhang(Northern Kentucky University), Simona Lattanzi(Marche Polytechnic University), Xiaoming Rong(Sun Yat-sen University), Joshua D. Palmer(The Ohio State University), Edward Chow(Sunnybrook Health Science Centre), Yaxuan Pi(Sun Yat-sen University), Paul D. Brown(Mayo Clinic), Charles B. Simone(New York Proton Center), Andreas A. Argyriou(Agios Andreas Hospital), Melvin L.K. Chua(Duke-NUS Medical School), Jingru Jiang(Sun Yat-sen University), Xiaohuang Zhuo(Sun Yat-sen University), Yi Li(Chongqing Institute of Green and Intelligent Technology), Jinpeng Lin(Sun Yat-sen University), Honghong Li(Hefei University of Technology), Xicheng Wang(Shandong University of Traditional Chinese Medicine), Zongwei Yue(Sun Yat-sen University), Yamei Tang(Sun Yat-sen University), Jinhua Cai, Jon Glass(Thomas Jefferson University)
Cited by 23
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k